We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$27.8B
AUM Growth
+$2.54B
Cap. Flow
+$477M
Cap. Flow %
1.71%
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 20.1%
2 Financials 16.78%
3 Healthcare 13.34%
4 Consumer Discretionary 9.48%
5 Communication Services 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
26
TSMC
TSM
$1.94T
$179M 0.64%
3,080,603
+31,159
+1% +$1.65M
CMCSA icon
27
Comcast
CMCSA
$87.3B
$166M 0.59%
3,682,398
+66,193
+2% +$2.95M
PFE icon
28
Pfizer
PFE
$143B
$160M 0.58%
4,312,582
-49,635
-1% -$1.77M
TMO icon
29
Thermo Fisher Scientific
TMO
$214B
$142M 0.51%
436,049
+5,891
+1% +$1.79M
KO icon
30
Coca-Cola
KO
$383B
$140M 0.5%
2,527,418
+94,650
+4% +$5.09M
C icon
31
Citigroup
C
$213B
$130M 0.47%
1,630,165
+65,765
+4% +$4.86M
TXN icon
32
Texas Instruments
TXN
$248B
$130M 0.47%
1,010,811
-39,105
-4% -$4.83M
MCD icon
33
McDonald's
MCD
$193B
$128M 0.46%
648,264
+9,357
+1% +$1.86M
NKE icon
34
Nike
NKE
$64.1B
$128M 0.46%
1,262,561
+61,826
+5% +$5.83M
CVX icon
35
Chevron
CVX
$382B
$127M 0.46%
1,057,776
-91,517
-8% -$10.8M
AMGN icon
36
Amgen
AMGN
$209B
$125M 0.45%
519,240
+26,373
+5% +$5.81M
ADBE icon
37
Adobe
ADBE
$105B
$122M 0.44%
368,940
+6,886
+2% +$2.03M
ABT icon
38
Abbott
ABT
$187B
$119M 0.43%
1,369,551
+7,153
+0.5% +$599K
COST icon
39
Costco
COST
$432B
$119M 0.43%
404,386
+15,877
+4% +$4.72M
HON icon
40
Honeywell
HON
$76.4B
$118M 0.42%
708,868
-4,496
-0.6% -$735K
UNP icon
41
Union Pacific
UNP
$174B
$116M 0.42%
640,362
+2,637
+0.4% +$451K
BA icon
42
Boeing
BA
$169B
$113M 0.41%
347,313
-5,138
-1% -$1.82M
NVS icon
43
Novartis
NVS
$302B
$112M 0.4%
1,182,476
-52,814
-4% -$4.74M
WFC icon
44
Wells Fargo
WFC
$254B
$111M 0.4%
2,057,867
+153,036
+8% +$8.02M
ORCL icon
45
Oracle
ORCL
$339B
$108M 0.39%
2,043,908
-15,661
-0.8% -$862K
DHR icon
46
Danaher
DHR
$138B
$103M 0.37%
756,426
-1,496
-0.2% -$189K
BMY icon
47
Bristol-Myers Squibb
BMY
$129B
$102M 0.37%
1,588,162
+651,003
+69% +$37.3M
TJX icon
48
TJX Companies
TJX
$179B
$101M 0.36%
1,659,398
-33,677
-2% -$1.99M
BABA icon
49
Alibaba
BABA
$276B
$97M 0.35%
457,193
+32,590
+8% +$6.12M
ABBV icon
50
AbbVie
ABBV
$465B
$96.6M 0.35%
1,091,002
+115,286
+12% +$9.57M

Similar funds

Aperio Group's Q4 2019 Portfolio in Review

As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
  • Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
  • Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
  • Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
  • Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
  • Aperio Group opened 92 new positions and closed 73 in Q4 2019.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.